P. Henrivaux

发表

Long-term management of insulin-treated diabetic patients with continuous subcutaneous insulin infusion.

J. Daubresse, P. Henrivaux, A. Bailly, 1983, Diabete & metabolisme.

B-cell response to a standardized breakfast in end-stage renal failure

J. Meunier, P. Lefèbvre, J. Daubresse, 2007, Acta diabetologia latina.

ACQUIRED IMMUNE DEFICIENCY SYNDROME IN BELGIUM AND ITS RELATION TO CENTRAL AFRICA a

H. Taelman, N. Clumeck, J. Sonnet, 1984, Annals of the New York Academy of Sciences.

Analysis of the interferon system in African patients with acquired immunodeficiency syndrome

N. Clumeck, P. Perre, K. Huygen, 1985, European Journal of Clinical Microbiology.

Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler® Real-time PCR

P. Henrivaux, P. Goubau, J. Ruelle, 2005, BMC infectious diseases.

U-100 Insulin Gives Some Protection Against Metabolic Deterioration Due to CSII Interruption

A. Scheen, P. Lefèbvre, P. Henrivaux, 1987, Diabetes Care.

Metabolic Alterations After a Two-hour Nocturnal Interruption of a Continuous Subcutaneous Insulin Infusion

A. Scheen, A. Scheen, P. Lefèbvre, 1984, Diabetes Care.

Prevention of Metabolic Alterations by Insulin Supplements Administered Either Before or After 2-h Nocturnal Interruption of CSII

G. Paolisso, A. Scheen, P. Lefèbvre, 1987, Diabetes Care.

Anti-Insulin Antibodies and Metabolic Deterioration After Interruption of Continuous Subcutaneous Insulin Infusion

A. Scheen, P. Lefèbvre, P. Henrivaux, 1986, Diabetes Care.

Lack of Systematic Metabolic Alterations After a One-hour Interruption of Continuous Subcutaneous Insulin Infusion in Type I Diabetic Patients

A. Scheen, P. Lefèbvre, P. Henrivaux, 1985, Diabetes Care.

Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in Type 1 (insulin-dependent) diabetic patients

J. Guiot, A. Scheen, P. Lefèbvre, 1989, Diabetologia.

ISOLATION OF AIDS VIRUS FROM CELL-FREE BREAST MILK OF THREE HEALTHY VIRUS CARRIERS

N. Clumeck, P. Perre, J. Lévy, 1985, The Lancet.

[Thrombotic thrombocytopenic purpura].

U. Gaspard, G. Fillet, G. Rorive, 1989, Revue medicale de Liege.

Purpura thrombotique thrombocytopénique

U. Gaspard, G. Fillet, G. Rorive, 1989 .

HIV‐1 proviral resistance mutations: usefulness in clinical practice

J. Yombi, B. Vandercam, P. Henrivaux, 2010, HIV medicine.

Effects of a standardized very-low-calorie diet on the plasma concentrations of trace elements in obese subjects.

A. Scheen, P. Henrivaux, G. Weber, 2009, Acta pharmacologica et toxicologica.

Human immunodeficiency virus type 1 ( HIV-1 ) proviral DNA load in purified CD 4 + cells by LightCycler ® Real-time PCR

P. Henrivaux, P. Goubau, J. Ruelle, 2016 .

LAV/HTLV-III infection in children of African origin: Experience in Belgium

H. Taelman, G. Zissis, N. Clumeck, 1986, European Journal of Pediatrics.

HIV‐1 proviral resistance mutations: usefulness in clinical practice

J. Yombi, P. Henrivaux, J. Ruelle, 2010, HIV medicine.

Derivation of an algorithm for optimal initial cyclosporine immunotherapy in kidney transplantation.

P. Bonnet, M. Meurisse, J. Defraigne, 1988, Transplantation Proceedings.